| 1 |
Abballe L, Spinello Z, Antonacci C, Coppola L, Miele E, Catanzaro G, Miele E. Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors' Cancer Stem Cells: Current Knowledge and Future Perspectives. Pharmaceutics 2023;15. [PMID: 36839827 DOI: 10.3390/pharmaceutics15020505] [Reference Citation Analysis]
|
| 2 |
Matias M, Santos AO, Silvestre S, Alves G. Fighting Epilepsy with Nanomedicines-Is This the Right Weapon? Pharmaceutics 2023;15. [PMID: 36839629 DOI: 10.3390/pharmaceutics15020306] [Reference Citation Analysis]
|
| 3 |
Bahadur S, Prakash A. A Comprehensive Review on Nanomedicine: Promising Approach for Treatment of Brain Tumor through Intranasal Administration. Curr Drug Targets 2023;24:71-88. [PMID: 36278468 DOI: 10.2174/1389450124666221019141044] [Reference Citation Analysis]
|
| 4 |
Teixeira MI, Lopes CM, Amaral MH, Costa PC. Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): a current overview of active targeting in brain diseases. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112999] [Reference Citation Analysis]
|
| 5 |
Simonis B, Vignone D, Gonzalez Paz O, Donati E, Falchetti ML, Bombelli C, Cellucci A, Auciello G, Fini I, Galantini L, Syeda RZ, Mazzonna M, Mongiardi MP, Buonocore F, Ceccacci F, Di Marco A, Mancini G. Transport of cationic liposomes in a human blood brain barrier model: Role of the stereochemistry of the gemini amphiphile on liposome biological features. J Colloid Interface Sci 2022;627:283-98. [PMID: 35853406 DOI: 10.1016/j.jcis.2022.07.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Naki T, Aderibigbe BA. Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer. Pharmaceutics 2022;14:1048. [DOI: 10.3390/pharmaceutics14051048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Meng J, Feng Z, Qian S, Wang C, Li X, Gao L, Ding Z, Qian J, Liu Z. Mapping physiological and pathological functions of cortical vasculature through aggregation-induced emission nanoprobes assisted quantitative, in vivo NIR-II imaging. Biomaterials Advances 2022;136:212760. [DOI: 10.1016/j.bioadv.2022.212760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Aldaz P, Arozarena I. Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter? Cancers (Basel) 2021;13:5799. [PMID: 34830952 DOI: 10.3390/cancers13225799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
